Safety and product quality
EmergingUSP safety review supports quality-monograph context for Spirulina maxima and Spirulina platensis, while LiverTox notes spirulina has not been proven effective for treating medical conditions and rare liver-injury reports exist.
Dose context: Powders, tablets, and blended greens products can differ in species, dose, quality testing, and contamination controls.
Caution: Product contamination, liver disease, autoimmune disease, and pregnancy/breastfeeding contexts deserve review.
Studies/sources: United States Pharmacopeia Safety Evaluation of Spirulina (2026-07-26), Spirulina (2026-07-26)